MBX Biosciences, Inc. Common Stock (MBX) Stock Analysis

MBX Biosciences, Inc. Common Stock (MBX) is a publicly traded company in the HEALTHCARE sector. It trades at $30.70, carries a market capitalization of $1.46B. This page summarizes the public market data, fundamentals, and frequently asked questions for MBX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $30.70
• Market Cap: $1.46B
• EPS: $-2.17
• 52-Week High: $45.85
• 52-Week Low: $9.43

Market Sentiment

MBX Biosciences, Inc. Common Stock currently has a Bullish sentiment score of 0.28.

About MBX Biosciences, Inc. Common Stock

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical firm based in Carmel, Indiana, dedicated to the discovery and development of cutting-edge precision peptide therapies targeting endocrine and metabolic disorders. Utilizing its proprietary technology platform, MBX is vigorously advancing its innovative therapeutic candidates through extensive clinical trials. By concentrating on critical unmet medical needs in its therapeutic areas, the company is well-positioned to achieve substanti...

GNG Research Analysis

GNG Research scores MBX Biosciences, Inc. Common Stock (MBX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MBX.

Frequently Asked Questions

Does MBX pay dividends?

MBX Biosciences, Inc. Common Stock (MBX) does not currently pay a regular dividend.

What is MBX's market cap?

MBX Biosciences, Inc. Common Stock (MBX) has a market capitalization of $1.46B with a current stock price of $30.70.